louisbrulenaudet/clinical-trials huggingface dataset:
Clinical trial NCT00611013: Magnetic Resonance Imaging and Spectroscopy at High Field
Official title: Magnetic Resonance Imaging and Spectroscopy at High Field
Study type: INTERVENTIONAL
Overall status: WITHDRAWN
Phase: NA
Conditions: Healthy
Keywords: Development of multi-purpose novel imaging protocols
Lead sponsor: University of California, Irvine
Sponsor class: OTHER
First posted: 2008-02-08
Enrollment: 0
Sex: ALL
Minimum age (years): 18
Maximum age (years): 90
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: BASIC_SCIENCE

Brief summary: Evaluating novel MR imaging techniques on volunteers.

Detailed description: The aim of this study is twofold. The first aim is to evaluate new MRI techniques developed by the investigators of this protocol on human volunteers. The second aim is to assist other investigators who need to use MR images obtained on this device for their own research. MR images and/or spectroscopy data will be acquired from the participants in this protocol.

Eligibility criteria: Inclusion Criteria:

* Healthy normal volunteers for imaging protocol optimization.

Exclusion Criteria:

* Patients with implanted surgical clips (hemostatic clips) or other ferromagnetic material,
* Patients engaged in occupations or activities which may cause accidental lodging of ferromagnetic materials, or who may have imbedded metal fragments from military activities,
* Patients with permanent (tattoo) eye-liner or with facial make-up (severe eye irritation has been reported),
* Patients with compromised thermoregulatory systems (e.g. certain cancer patients),
* Patients with metallic implants, because they may cause artifacts in diagnostic images due to magnetic field distortion,
* Patients with implanted prosthetic heart valves,
* Patients with pacemakers, neuro-stimulation devices,
* Pregnant patients (the safety of magnetic resonance examination has not been completely established for embryos and fetuses),
* Subjects who have received orthodontic work involving ferromagnetic materials,
* Subjects who have claustrophobia, and
* The patients unwilling to participate in the study or fail to sign the consent form.
* Subjects who are pregnant or breast-feeding will be excluded from the contrast enhanced MRI studies.
* Subjects who had allergic response to contrast agents previously will be excluded from contrast enhanced MRI studies.
* Subjects with known history of asthma, allergic conditions, severe renal insufficiency, sickle cell anemia, chronic hemolytic anemia, gastrointestinal disorders will also be excluded from contrast enhanced MRI studies.

Primary outcomes:
measure: General purpose novel magnetic resonance imaging contrasts, developments for improved magnetic resonance image quality
timeFrame: 10 years
Secondary outcomes:
Other outcomes:
Locations:
city: Irvine
country: United States
facility: Center for Functional Onco-Imaging, University of California
state: California
Study officials:
affiliation: University of California, Irvine
name: Lutfi T Muftuler, Ph.D.
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT03082313: Movement-based Infant Intervention
Official title: Movement-based Intervention to Promote Positive Neurodevelopmental Outcomes in Infants at Risk for Developmental Delay
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Infant Development
Infant,Premature
Infant, Very Low Birth Weight
Infant, Small for Gestational Age
Infant Conditions
Keywords: infant
leg movement
wearable sensors
early intervention
Lead sponsor: University of Southern California
Sponsor class: OTHER
First posted: 2017-03-17
Enrollment: 12
Sex: ALL
Minimum age (years): 3
Maximum age (years): 9
Standard ages: CHILD
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: The objective is to pilot test the effectiveness of an evidence-based intervention to promote positive neurodevelopmental outcomes in infants at risk for developmental delay. The intervention promotes movement experience from 3 months to sitting onset.

Detailed description: Aim: Our purpose was to assess daily leg movement rate before and after a caregiver-provided in-home intervention for infants at risk for developmental disability. We also assessed adherence and quality of caregiver-child interaction.

Methods: Twelve infants, at risk for developmental disabilities, and their caregivers participated in an intervention focused on increasing leg movements. Intervention started between 3- and 6-months cor- rected age and ended once the infant was able to sit independently or at 9 months corrected age, whichever occurred first. Infants were assessed monthly.

Eligibility criteria: Inclusion Criteria:

* Infants will be 3 months of adjusted age at the first visit, +/- 10 days. Infants will be defined as at risk if they qualify for high risk infant follow up care as defined by California Children's Services.

Exclusion Criteria:

* Infants with congenital malformations of the legs will be excluded.

Primary outcomes:
measure: Movement Rate
timeFrame: post intervention (intervention duration ranged from 2-6 months)
Secondary outcomes:
Other outcomes:
Locations:
city: Los Angeles
country: United States
facility: Infant Neuromotor Control Laboratory
state: California
Study officials:
affiliation: University of Southern California
name: Beth A Smith, PT, PhD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT03871413: TRV-chair vs Manual Repositioning Maneuver in Treatment of Benign Paroxysmal Positional Vertigo
Official title: Can Benign Paroxysmal Positional Vertigo (BPPV) be Treated Faster and More Efficiently by Using a Mechanical Rotational Chair Compared to the Traditional Manual Repositioning Maneuvers?
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: BPPV
Keywords: Benign Paroxysmal Positional Vertigo
Vertigo
Dizziness
Vestibular Diseases
Epley Maneuver
TRV-chair
Repositioning chair
Lead sponsor: Aalborg University Hospital
Sponsor class: OTHER
First posted: 2019-03-12
Enrollment: 170
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Comparison of treatment efficacy of a mechanical rotational chair (TRV-chair) vs. manual repositioning maneuvers in BPPV

Detailed description: Open-label, randomized controlled trial comparing manual repositioning maneuvers with a mechanical rotational chair (TRV-chair) in diagnosing and treating BPPV. Patients with suspected BPPV will be randomized to either manual repositioning maneuvers or the TRV-chair.

Eligibility criteria: Inclusion Criteria:

* Characteristic (for BPPV) positional nystagmus
* Positive Dix-Hallpike
* Positive supine roll test
* Medical history compatible with BPPV

Exclusion Criteria:

* Treatment in TRV-chair within the last 6 months
* Exclusion of BPPV diagnosis
* Lack of treatment cooperation
* Known cerebral aneurism or cerebral hemorrhage
* Diagnosed and treated for BPPV within the past month
* Treatment with sedating anti-histamines within the past 7 days

Primary outcomes:
measure: Number of treatments
timeFrame: 2 years
measure: Treatment success after first treatment
timeFrame: 2 years
Secondary outcomes:
measure: Dizziness Handicap Inventory (DHI) questionnaire
timeFrame: 2 years
measure: Adverse events
timeFrame: 2 years
Other outcomes:
Locations:
city: Aalborg
country: Denmark
facility: Department of Otolaryngology, Head & Neck Surgery and Audiology
state: North Denmark Region
Study officials:
affiliation: Aalborg University Hospital
name: Dan D Hougaard, MD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT06719713: Store Safely: Rural Firearm Injury Prevention for Families
Official title: Store Safely: Rural Firearm Injury Prevention for Families
Study type: INTERVENTIONAL
Overall status: NOT_YET_RECRUITING
Phase: NA
Conditions: Firearm Injury
Keywords: rural
firearm safe storage
injury prevention
suicide prevention
community education
Lead sponsor: University of Michigan
Sponsor class: OTHER
Collaborators: name: Centers for Disease Control and Prevention
name: Marquette County Health Department
First posted: 2024-12-06
Enrollment: 600
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Waitlist control and intervention
Primary purpose: PREVENTION

Brief summary: The researchers are testing a firearm safety prevention strategy tailored for families with children who reside in a rural area. Researchers hypothesize that the intervention will lead to improvements in household firearm storage.


Eligibility criteria: Inclusion Criteria:

* Provision of signed and dated informed consent form
* English-speaking
* Have a child under 18 living at home
* Own at least one firearm
* Reside in Michigan's Upper Peninsula (UP)
* Access to a computer/mobile device and wifi
* Have sufficient information about household storage to complete surveys

Exclusion Criteria:

* Unable to be consented in English
* Lack of firearm in the home
* No child in the home
* Residence outside the UP
* No access to technology
* Previously enrolled in 2020 pilot project

Primary outcomes:
measure: Number of firearms stored locked
timeFrame: Approximately 6 months
measure: Parent Engagement in Harm Reduction Firearm Storage Behaviors Score
timeFrame: Approximately 6 months
Secondary outcomes:
measure: Parent Self-Efficacy for Firearm Safety Questionnaire
timeFrame: Baseline, Immediate/2-Week
measure: Number of firearms unloaded
timeFrame: Approximately 6 months
measure: Number of firearms unlocked and loaded
timeFrame: Approximately 6 months
Other outcomes:
Locations:
city: Ann Arbor
country: United States
facility: University of Michigan
state: Michigan
city: Negaunee
country: United States
facility: Marquette County Health Department
state: Michigan
Study officials:
affiliation: University of Michigan
name: Cynthia Ewell Foster, Ph.D.
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT00435513: A Common Polymorphism of the SRD5A2 Gene is Not Associated With Male-to-Female and Female-to-Male Transsexualism
Official title: Association Study of a SRD5A2 SNP and Transsexualism.
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Transsexualism
Lead sponsor: Medical University of Vienna
Sponsor class: OTHER
First posted: 2007-02-15
Enrollment: 1770
Sex: ALL
Minimum age (years): 18
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: CASE_CONTROL
Time perspective: RETROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Female-to-male transsexuals and male-to-female transsexuals

Brief summary: Genetic variations, i.e. polymorphisms, may be associated with gender dysphoria, e.g. transsexualism. This study aims to identify such variations.

Detailed description: Context: Early developmental exposure of the brain to sex steroids may play a role in the etiology of transsexualism.

Objective: To assess the association between transsexualism and allele and genotype frequencies of the steroid 5-alpha reductase (SRD5A2) Val89Leu polymorphism.

Design and Patients: We performed a case-control study of 100 male-to-female (MtF) transsexuals, 47 female-to-male (FtM) transsexuals, 755 male controls, and 915 female controls. DNA was extracted from buccal swabs and genotypes were determined by polymerase chain reaction.

Results: SRD5A2 Val89Leu allele frequencies (SRD5A2 V: 137/200 \[69%\] and SRD5A2 L: 63/200 \[31%\] vs. SRD5A2 V: 1065/1510 \[71%\] and SRD5A2 L: 445/1510 \[29%\], respectively; p=0.6; Odds Ratio \[OR\] 1.10; 95% Confidence Interval \[CI\] 0.76-1.58) and genotype distributions (SRD5A2 V/V+V/L: 92/100 \[92%\] and L/L 8/100 \[8%\] vs. SRD5A2 V/V+V/L: 683/755 \[91%\] and L/L 72/755 \[9%\], respectively, p=0.7; OR 0.82; 95% CI 0.24-2.84) were not significantly different between MtF transsexuals and male controls. SRD5A2 Val89Leu allele frequencies (SRD5A2 V: 70/94 \[74%\] and SRD5A2 L: 24/94 \[26%\] vs. SRD5A2 V: 1253/1830 \[69%\] and SRD5A2 L: 573/1830 \[31%\], respectively; p=0.3; OR 0.75; 95% CI 0.45-1.26) and genotype distributions (SRD5A2 V/V+V/L: 44/47 \[93%\] and L/L 3/47 \[7%\] vs. SRD5A2 V/V+V/L: 823/915 \[90%\] and L/L 92/915 \[10%\], respectively, p=0.6; OR 0.61; 95% CI 0.11-3.32) were also not significantly different between FtM transsexuals and female controls. Of note, there was no gender-specific genotype distribution among controls.

Conclusions: The SRD5A2 Val89Leu polymorphism is not associated with transsexualism and is no candidate gene of this condition.

Eligibility criteria: Inclusion Criteria:

* transsexual individuals as defined by DSM IV criteria

Exclusion Criteria:

* unwillingness to participate

Primary outcomes:
Secondary outcomes:
Other outcomes:
Locations:
city: Vienna
country: Austria
facility: University of Vienna, Vienna, Austria
Study officials:
affiliation: Univ. of Vienna
name: Clemens B Tempfer, MD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT05746936: Robotic Versus Laparoscopic Roux En-y Gastric Bypass
Official title: Can Robotic Gastric Bypass be Considered a Valid Alternative to Laparoscopy: Our Early Experience
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Roux-en-y Anastomosis Site
Obesity, Morbid
Bypass Complication
Anastomosis; Complications
Surgery-Complications
Lead sponsor: University of Foggia
Sponsor class: OTHER
First posted: 2023-02-28
Enrollment: 33
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Observational model: COHORT
Time perspective: RETROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Body mass index (BMI) ≥35-39 kg/m2 with one obesity- associated co-morbidity or BMI≥40kg/m2, age ≥ 18 years. Before surgery, patients underwent a standardized psychological and physical evaluation which includes blood chemistry tests, chest x-rays, electrocardiogram and cardiological examinations, nutritional evaluation, esophagogastroduodenoscopy, spirometry and psychiatric evaluation .

Brief summary: This study retrospectively identified 33 consecutive obese patients who underwent either laparoscopic or robotic gastric bypass procedures over a 2-year period.


Eligibility criteria: Inclusion Criteria:

* Body mass index (BMI) ≥35-39 kg/m2 with one obesity- associated co-morbidity
* BMI≥40kg/m2, age ≥ 18 years.

Exclusion Criteria:

* Re-do surgery procedures

Primary outcomes:
measure: differences between the robotic and laparoscopic gastric bypass
timeFrame: two years period
measure: differences between the robotic and laparoscopic gastric bypass
timeFrame: two years period
measure: differences between the robotic and laparoscopic gastric bypass
timeFrame: two years period
measure: differences between the robotic and laparoscopic gastric bypass
timeFrame: two years period
Secondary outcomes:
Other outcomes:
Locations:
city: Foggia
country: Italy
facility: University of Foggia
Study officials:
References:
Clinical trial NCT05091736: System Accuracy of the Blood Glucose Monitor for Personal Use BG-709b
Official title: Evaluierung Der Systemgenauigkeit Des BG-709b Blood Glucose Monitoring Systems Der Firma Sejoy gemäß DIN EN ISO 15197:2015
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Diabetes Mellitus
Lead sponsor: Institut fur Diabetes Karlsburg GmbH
Sponsor class: OTHER
Collaborators: name: Hangzhou Sejoy Electronics & Instrument Co., ltd. Joytech Healthcare Co., ltd., PRC
First posted: 2021-10-25
Enrollment: 120
Sex: ALL
Minimum age (years): 18
Maximum age (years): 99
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: DIAGNOSTIC

Brief summary: This study assesses the system accuracy a blood glucose monitoring systems pursuant to ISO 15197

Detailed description: This study assesses the system accuracy the blood glucose monitoring systems for personal use BG-709b as outlined in DIN EN ISO 15197:2015.

Eligibility criteria: Inclusion Criteria:

* Male or female patients with clinical indication for blood glucose testing
* Signed form of consent
* Minimum age of 18 years
* Subjects are legally competent and capable to understand character, meaning and consequences of the study

Exclusion Criteria:

* Pregnancy or lactation
* Severe acute disease (at study physician's discretion)
* Acute or chronic diseases with inherent risk of aggravation by the procedure (at study physician's discretion)
* Current constitution that does not allow participating in the study (e.g. hematocrit out of the devices's specifications, medication known to influence blood glucose measurements; Appendix A of ISO 15197)
* Being unable to give informed consent
* Age younger than 18 years
* Legally incompetent

Primary outcomes:
measure: Analysis of system accuracy based on DIN EN ISO 15197
timeFrame: day 1
Secondary outcomes:
Other outcomes:
Locations:
city: Karlsburg
country: Germany
facility: Institut für Diabetes Karlsburg GmbH
state: Mecklenburg Vorpommern
Study officials:
affiliation: Institut fur Diabetes Karlsburg GmbH
name: Eckhard Salzsieder, PhD
role: STUDY_DIRECTOR
References:
Clinical trial NCT04722536: Effectiveness of Cervico-isthmic Cerclage
Official title: Effectiveness of CERvico-isthmic CErclage in Increasing the Rate of Live Births in Case of a History of Late Miscarriage and/or Premature Delivery
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Cerclage, Cervical
Cervical Insufficiency
Keywords: cervico-isthmic cerclage
cerclage
cervico-isthmic
cervical insufficiency
miscarriage
prematurity
Lead sponsor: Hospices Civils de Lyon
Sponsor class: OTHER
First posted: 2021-01-25
Enrollment: 45
Sex: FEMALE
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: RETROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients who have had cervico-isthmic cerclage between January 1, 2010 and April 1, 2019, in 3 University Hospitals of Lyon (Lyon Sud Hospital, HFME Hospital and Croix-Rousse Hospital).

Brief summary: This study compares the rate of live births before and after cervico-isthmic cerclage in 3 hospitals in the last 10 years. The hypothesis is that cerclage significantly increases the rate of live births in women with cervical insufficiency.


Eligibility criteria: Inclusion Criteria:

* History of premature delivery or late miscarriage unrelated to maternal pathology, chorioamnionitis, fetal or placental pathology
* Patient aged over 18 at the time of the phone call
* Cerclage performed according to the Benson technique verified on the operative report
* Cerclage performed in one of the 3 obstetric gynecology departments of the CHU de Lyon (Lyon Sud, Croix Rousse and HFME) between January 1, 2010 and April 1, 2019

Exclusion Criteria:

* History of trachelectomy
* Surgical technique not specified or not deductible from the operating report
* Refusal to participate in the study
* Patient under legal protection

Primary outcomes:
measure: Number of live birth ≥ 24 weeks of gestation or before 24 weeks of gestation with active neonatal intensive care, among pregnancies progressing after 14 weeks of gestation.
timeFrame: Day 0 (At Inclusion)
Secondary outcomes:
Other outcomes:
Locations:
city: Bron
country: France
facility: Hôpital Femme Mère Enfant (HFME) - Hospices Civils de Lyon
city: Lyon
country: France
facility: Hôpital de la Croix Rousse - Hospices Civils de Lyon
city: Pierre-Bénite
country: France
facility: Centre Hospitalier Lyon Sud (CHLS) - Hospices Civils de Lyon
Study officials:
affiliation: Service de gynécologie-obstétrique - Centre Hospitalier Lyon Sud
name: DEBORAH GAVANIER, MD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT00272636: Radiofrequency Catheter Ablation for Chronic Atrial Fibrillation
Official title: Randomized Comparison of Radiofrequency Catheter Ablation vs. Antiarrhythmic Therapy With Amiodarone for Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Atrial Fibrillation
Keywords: atrial fibrillation
catheter ablation
amiodarone
cardioversion
Lead sponsor: University of Michigan
Sponsor class: OTHER
Collaborators: name: San Raffaele University Hospital, Italy
First posted: 2006-01-06
Enrollment: 140
Sex: ALL
Minimum age (years): 18
Maximum age (years): 70
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The purpose of this study is to determine the long-term efficacy of radiofrequency catheter ablation in patients with chronic atrial fibrillation.


Eligibility criteria: Inclusion Criteria:

* Chronic atrial fibrillation

Exclusion Criteria:

* Left atrial diameter \>55 mm
* Left ventricular ejection fraction \<0.30
* Contraindication to amiodarone therapy or anticoagulation with warfarin
* Presence of a mechanical prosthetic valve
* History of a cerebrovascular accident
* Presence of left atrial thrombus on TEE
* Prior attempt at catheter or surgical ablation for atrial fibrillation

Primary outcomes:
measure: Freedom from atrial fibrillation and atrial flutter in the absence of antiarrhythmic drug therapy at 1 year.
Secondary outcomes:
measure: incidence of complications
measure: changes in left atrial diameter
measure: changes in left ventricular ejection fraction
measure: changes in symptom severity
Other outcomes:
Locations:
city: Ann Arbor
country: United States
facility: University of Michigan Health System
state: Michigan
city: Milan
country: Italy
facility: San Raffaele Hospital
Study officials:
affiliation: University of Michigan
name: Hakan Oral, MD
role: PRINCIPAL_INVESTIGATOR
affiliation: University of Michigan
name: Fred Morady, MD
role: STUDY_CHAIR
References:
Clinical trial NCT05873036: Comparison of AT & PR Training to Improve Functional Ability After Breast Cancer Surgery
Official title: Comparison of Aerobic Training and Progressive Resistance Training to Improve Functional Ability After Breast Cancer Surgery
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Breast Cancer
Lead sponsor: Superior University
Sponsor class: OTHER
First posted: 2023-05-24
Enrollment: 74
Sex: FEMALE
Minimum age (years): 35
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: To determine the effect of aerobic training and progressive resistance training to improve upper limb functional ability after breast cancer surgery


Eligibility criteria: Inclusion Criteria:

* a) Breast cancer female survivors eligible under 35-65 years complaining of cancer-related fatigue.

  b) Adjunctive radiotherapy or underwent surgery (lumpectomy or mastectomy), willing to participate will be included in the study.

  c) Shoulder pain d) Decreased ROM e) Primary unilateral BC, ALND, no distant metastases, no previous ALND on the contra lateral side f) No previous history of arm lymph edema

Exclusion Criteria:

- a) Survivors with other concurrent metastasis anywhere else in the body, diagnosed case of any cardiac or respiratory condition, contra-indicated for exercise training (severe dyspnea, chest pain, severe nausea, ataxia, dizziness etc.) b) Any other neurological or recent musculoskeletal problems were excluded from the study.

c) Bilateral mastectomy d) Adjunctive chemotherapy

Primary outcomes:
measure: Numerical pain rating scale (NPRS)
timeFrame: 6 Months
measure: Goniometer Tool
timeFrame: 6 Months
Secondary outcomes:
Other outcomes:
Locations:
city: Lahore
country: Pakistan
facility: Chaudhary Muhammad Akram Teaching and research hospital, Jinnah Hospital Lahore and Mayo Hospital Lahore
state: Punjab
Study officials:
References: